MASI Masimo Corporation

XNAS 179.97 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

MASI $179.97 —
Key stats
$179.97
52-Week Range
$125.94 – $179.99
YTD
+41.26%
IV Rank (30D)
0.0
Straddle Price
$0.38
P/C Vol Ratio
0.00
Market Cap
$9.4B
Open
$179.95
Day Range
$179.95 – $179.99
Volume
3,160,100
Prev Close
$179.94
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.55%
Beta vs SPY1.00
Cost of Equity (CAPM)10.05% (VRP-adj)
WACC9.75%
Volatility Risk Premium+17.9pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.3%
Rev. Growth (YoY, DCF input)+8.8%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.09 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.2B
Return on Equity (TTM)9.7%
Book / Price8.1%
Gross Margin (TTM)61.7%
FCF Margin (TTM)13.5%
Debt / Equity0.56
Quality Score2/6 — normal (10y DCF)
Market-Implied Growth+23.9% (reverse-DCF on current price)
SMA 50$178.55 (Market Anchor value)
SMA 20 / Bollinger Mid$178.78
Bollinger Width / SMA200.5% (drives anchor stability)
Net Debt$0.3B
Market Cap$10B
Peers used for multiples: DXCM, GEHC, HIMS, IRTC, ISRG, OSCR, PODD, RMD
Model Conviction
71%
20-Day Fair Value
≈ by Jul 9, 2026
$170.59
α -5.2% rank 26%
40-Day Fair Value
≈ by Aug 7, 2026
$168.46
α -6.4% rank 26%
60-Day Fair Value
≈ by Sep 7, 2026
$166.35
α -7.6% rank 26%
MethodImplied PriceWeightDetail
DCF $73.55 24%
DDM (Gordon) n/a 0%
Peer P/E $48.41 7% median 31.8× · 5 peers
Peer EV/EBITDA $138.36 7% median 20.6× · 6 peers
Peer P/B $120.82 7% median 8.3× · 8 peers
Peer P/S $127.04 7% median 4.0× · 8 peers
Market Anchor (SMA50) $178.55 48% stability 100% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-10 · updated
About
Industry (SIC)
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS (3845) · industry map
Exchange
XNAS
Market Cap
$9.4B
Employees
2,200
List Date
2007-08-08
CIK
0000937556
Headquarters
Irvine, CA
Homepage
https://www.masimo.com

Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 7015 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $178.78
SMA 50: $178.55
SMA 200: $155.90
Current: $179.95
EMA 12: $179.06
EMA 26: $178.68
MACD: 0.3727 | Signal: 0.0674
BULLISH
ADX (14): 35.88
TREND
+DI: 32.13
−DI: 7.92

Momentum Oscillators

RSI (14): 74.84
OVERBOUGHT
Stoch %K: 90.04
Stoch %D: 85.97
Williams %R: -2.37

Volume & Volatility

BB Upper: $179.62
BB Lower: $177.95
OVERBOUGHT
OBV: 44,305,202
Vol SMA 20: 1,006,775
Vol ROC: 247.03%
ATR: $0.39
True Range: $0.05
HV 20: 2.5%
HV 30: 2.3%
HV 60: 4.0%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-06-11T00:00:00 – 2026-06-09T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary Confidence Level: 8/10 (BULLISH)

Key Drivers:

  • Recent positive news headlines highlighting the company's growth and financial performance
  • Strong technical signals, including a bullish MACD crossover and overbought RSI
  • Low volatility and beta compared to market

Primary Risks:

  • Potential for a pullback as stock has risen sharply in recent weeks
  • Uncertainty surrounding upcoming earnings release and potential impact on stock price

Investment Thesis: MASI presents an attractive buying opportunity due to its strong fundamental performance, positive technical indicators, and low volatility. However, caution should be exercised due to the potential for a pullback.

Recent News Sentiment Impact: Positive news headlines have contributed significantly to the stock's upward momentum, with sentiment analysis indicating a strong positive bias.

Technical Analysis

Trend Direction: Short-term - Bullish, Medium-term - Bullish

Support/Resistance Levels:

  • Lower Bollinger Band: $177.95
  • Upper Bollinger Band: $179.62
  • SMA 20: $178.78
  • EMA 12: $179.06

Momentum Signals:

  • RSI (14): Overbought (74.84) - potential sell signal
  • MACD: Bullish crossover (0.37 / Signal: 0.07)
  • Bollinger Bands: Overbought (Signal: overbought)

Volume Analysis:

  • Volume SMA 20: 1006775.85
  • On-Balance Volume (OBV): 44305202.73

News & Sentiment Analysis

Recent Headlines Summary:

  • Positive news headlines highlighting growth and financial performance
  • Neutral headline discussing merger investigation
  • Negative headlines surrounding shareholder alerts and potential earnings misses

Sentiment Assessment: Positive (Positive news headlines outweigh negative sentiment)

Catalyst Identification:

  • Upcoming earnings release, which could impact stock price

Market Narrative: Recent positive news headlines have driven the stock's upward momentum, aligning with technical signals. However, caution should be exercised due to potential for a pullback and uncertainty surrounding upcoming earnings.

Risk & Volatility Assessment

Beta Interpretation: Low risk (0.28 vs SPY)

Volatility Regime: Low volatility

Options Market Signals:

  • IV Rank: 18.1% (Low)
  • Current IV: 20.2%
  • Expected Move: $0.38 (38 DTE), 7-DTE: $0.28
  • Volume Flow: Bullish (11 calls vs 0 puts)

Downside Protection: Support levels at SMA 20 and lower Bollinger Band

Market Context & Positioning

Sector Performance:

  • Relative strength within the healthcare sector

Institutional Activity:

  • Institutional investors have been accumulating shares, suggesting potential support for the stock

Correlation Analysis:

  • Stock moves less than market (0.08 correlation)

Relative Valuation: Position within trading range

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $178.78
  • Lower Bollinger Band: $177.95

Breakout/Breakdown Levels:

  • Upper Bollinger Band: $179.62 (potential sell signal)

Time-Sensitive Catalysts:

  • Upcoming earnings release, which could impact stock price

Risk Management: Stop-loss levels at SMA 20 and lower Bollinger Band; consider position sizing considerations.

Note: This analysis is based on the provided data and should not be considered as a buy or sell recommendation.

Generated
Earnings History
15 of 22 under expected move
Avg Expected Move
8.04%
Avg Actual Move
6.48%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-01-13 After-Close 2.46% 5.25% 2.13x Exceeded
2021-04-26 After-Close 5.89% 5.50% 0.93x Within
2021-07-27 After-Close 6.41% 1.54% 0.24x Within
2021-10-26 After-Close 6.85% 0.12% 0.02x Within
2022-01-11 After-Close 1.79% 0.46% 0.26x Within
2022-03-30 After-Close 1.90% 6.34% 3.34x Exceeded
2022-08-09 After-Close 9.99% 6.49% 0.65x Within
2022-11-08 After-Close 8.86% 9.90% 1.12x Exceeded
2023-02-28 After-Close 8.67% 5.15% 0.59x Within
2023-05-09 After-Close 7.11% 5.26% 0.74x Within
2023-07-17 After-Close 3.69% 20.00% 5.42x Exceeded
2023-11-07 After-Close 16.56% 3.71% 0.22x Within
2024-01-10 After-Close 7.32% 0.50% 0.07x Within
2024-02-27 After-Close 10.30% 1.08% 0.10x Within
2024-05-07 After-Close 8.20% 11.75% 1.43x Exceeded
2024-08-06 After-Close 9.43% 11.29% 1.20x Exceeded
2024-11-05 After-Close 12.04% 10.60% 0.88x Within
2025-02-25 After-Close 12.71% 12.35% 0.97x Within
2025-05-06 After-Close 10.13% 7.04% 0.69x Within
2025-08-05 After-Close 9.37% 11.73% 1.25x Exceeded
2025-11-04 After-Close 12.21% 4.61% 0.38x Within
2026-01-12 After-Close 5.05% 1.82% 0.36x Within

Earnings calendar: this week’s reports with expected vs actual moves →

MASI Options Activity & IV Rank

MASI IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 3.1%
7-DTE IV: 9.9%
Expected Move: $0.38
7-DTE Move: $0.28
Days to Exp: 38 (2026-07-17)

Options Flow

Call Volume: 11
Put Volume: 0
P/C Volume: —
BULLISH
Call OI: 77
Put OI: 0
P/C OI: —
Total OI: 77

ATM Options Pricing

ATM Call: $0.05
ATM Put: $0.33
Call %: 0.0%
Put %: 0.2%

Chain Summary

Chain Volume: 6,918
Chain OI: 33,693
Last Updated: 6/9/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 99th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
99%
vs own history
GEX tilt
+0.98
OI-weighted, today
Vanna tilt
+0.85
δ-sensitivity to IV
Charm tilt
-0.99
δ-decay vs time
Vanna tilt +0.85: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.99: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 24 ATM contracts, 28k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Jun 9 · No data
30 DTE / 10d —
— pts EXTREME
as of Jun 9 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)8.8LowJun 9
IV Rank (30 DTE)0.0LowJun 9
Straddle Price (30 DTE)$0.38Jun 9
Beta Analysis
Insufficient price history — listed 7015 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.

MASI Institutional Ownership (13F)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

# Filer Shares Value % of Total % of Float Period
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

MASI Insider Trading (Form 4)

Latest: 2026-05-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-05 Elisabeth A Hellmann Chief Human Resources Officer Mixed +214 $178.43 -$21.6K EDGAR
2026-05-05 Michelle Brennan Director Exer (M) +1,225 — EDGAR
2026-05-05 Wendy E Lane Director Exer (M) +1,225 — EDGAR
2026-05-05 Timothy J Scannell Director Exer (M) +1,225 — EDGAR
2026-03-16 Micah W Young EVP & Chief Financial Officer Mixed +402 $175.47 -$82.6K EDGAR
2026-03-16 Catherine M. Szyman CEO Mixed +1,032 $175.47 -$187.6K EDGAR
2026-03-13 Quentin Koffey Other (J) +1,094,200 RSU — EDGAR
2026-03-10 Catherine M. Szyman CEO Grant (A) +39,904 RSU — EDGAR
2026-03-10 Micah W Young EVP & Chief Financial Officer Grant (A) +17,671 RSU — EDGAR
2026-03-10 Charles Dadswell EVP, General Counsel Grant (A) +10,261 RSU — EDGAR
2026-03-10 Anand Sampath EVP, Operations Grant (A) +6,840 RSU — EDGAR
2026-03-10 Elisabeth A Hellmann Chief Human Resources Officer Grant (A) +5,985 RSU — EDGAR
2026-03-10 Tim Benner Chief Marketing Officer Grant (A) +6,128 RSU — EDGAR
2026-03-10 Greg Allen Meehan Chief Commerical Officer Grant (A) +8,550 RSU — EDGAR
2026-03-03 Micah W Young EVP & Chief Financial Officer Mixed +6,907 $175.35 -$1.42M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

MASI Insider Holdings

16 insiders · @ $179.95
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Politan Capital Management LP 4,589,648 $825.91M $0 2 2025-08-29
2 Anand Sampath EVP, Operations 59,589 $10.72M -$36.58M 30 2026-03-10
3 Bilal Muhsin Chief Operating Officer 34,172 $6.15M -$19.81M 21 2025-05-14
4 Tao Levy EVP, Bus Dev 26,810 $4.82M -$826.4K 11 2024-11-15
5 Micah W Young EVP & Chief Financial Officer 25,656 $4.62M -$8.21M 22 2026-03-16
6 Blair Tripodi COO, Consumer Division 21,896 $3.94M $0 4 2025-09-25
7 Craig B Reynolds Director 18,371 $3.31M -$17.73M 18 2025-05-01
8 Catherine M. Szyman CEO 8,674 $1.56M $0 5 2026-03-16
9 Michelle Brennan Interim CEO 8,543 $1.54M $30.6K 8 2026-05-05
10 William R Jellison Director 4,790 $862.0K $437.9K 3 2025-08-12
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

MASI Board & Officers

As of SEC filings through Jun 12, 2026

Directors 1

Officers 1

  • Omar Ahmed · CTIO & EVP of Engineering · since Jul 31, 2025
Changes in the last 10 years (55)
Jun 12, 2026Wendy E Lane reported in an SEC filing no longer being a director
Jun 12, 2026Timothy J Scannell reported in an SEC filing no longer being a director
Jun 12, 2026Tim Benner reported in an SEC filing no longer being Chief Marketing Officer
Jun 12, 2026Quentin Koffey reported in an SEC filing no longer being a director
Jun 12, 2026Paul Hataishi reported in an SEC filing no longer being SVP, Chief Accounting Officer
Jun 12, 2026Michelle Brennan reported in an SEC filing no longer being a director
Jun 12, 2026Micah W Young reported in an SEC filing no longer being EVP & Chief Financial Officer
Jun 12, 2026Greg Allen Meehan reported in an SEC filing no longer being Chief Commerical Officer
Jun 12, 2026Elisabeth A Hellmann reported in an SEC filing no longer being Chief Human Resources Officer
Jun 12, 2026Darlene J. S. Solomon reported in an SEC filing no longer being a director
Jun 12, 2026Charles Dadswell reported in an SEC filing no longer being a director
Jun 12, 2026Charles Dadswell reported in an SEC filing no longer being EVP, General Counsel
Jun 12, 2026Catherine M. Szyman reported in an SEC filing no longer being a director
Jun 12, 2026Catherine M. Szyman reported in an SEC filing no longer being CEO
Jun 12, 2026Anand Sampath reported in an SEC filing no longer being EVP, Ops & Clinical Research
Mar 10, 2026Charles Dadswell first listed as EVP, General Counsel in an SEC filing
Sep 25, 2025Blair Tripodi reported in an SEC filing no longer being COO, Consumer Division
Aug 18, 2025The company announced the departure of William R Jellison from the board in an SEC filing
Aug 18, 2025Charles Dadswell became a director
Jul 31, 2025Tim Benner became Chief Marketing Officer
Not reported recently (17)
  • Tao Levy · Last reported as EVP, Bus Dev in an SEC filing dated Nov 15, 2024
  • Joe E Kiani · Last reported as a director in an SEC filing dated Sep 25, 2024
  • Thomas Samuel McClenahan · Last reported as EVP, Gen Counsel & Corp Sec in an SEC filing dated Mar 1, 2024
  • H Michael Cohen · Last reported as a director in an SEC filing dated Jun 26, 2023
  • Julie Ann Shimer · Last reported as a director in an SEC filing dated Jun 26, 2023
  • Kevin P Duffy · Last reported as President, Consumer in an SEC filing dated Apr 14, 2022
  • Thomas Harkin · Last reported as a director in an SEC filing dated Jun 1, 2021
  • Yongsam Lee · Last reported as EVP & CIO in an SEC filing dated Mar 2, 2021
  • Jon Coleman · Last reported as Pres-WW OEM & Global Health in an SEC filing dated Mar 2, 2021
  • John Todd Koning · Last reported as SVP, Chief Accounting Officer in an SEC filing dated Mar 2, 2021
  • Steven Barker · Last reported as a director in an SEC filing dated Jun 2, 2020
  • Sanford Fitch · Last reported as a director in an SEC filing dated Jun 2, 2020
  • David J Van Ramshorst · Last reported as SVP, Chief Accounting Officer in an SEC filing dated Apr 15, 2020
  • Rick Fishel · Last reported as Pres, WW OEM Business... in an SEC filing dated Jul 18, 2017
  • Mark de Raad · Last reported as EVP & Chief Financial Officer in an SEC filing dated Jun 7, 2017
  • Thierry Leclercq · Last reported as EVP, Bus Dev in an SEC filing dated May 10, 2017
  • Paul Jansen · Last reported as EVP, Bus Dev in an SEC filing dated Mar 10, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

MASI Proposed Insider Sales (Form 144)

Latest: 2026-01-28
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-01-28 Sampath Anand Officer 18,680 $2.56M 2026-01-28 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2025-12-11 Tripodi Blair Former Affiliate 17,118 $2.43M 2025-12-11 Charles Schwab & Co., Inc. — EDGAR
2025-11-28 Ahmed Omar Officer 3,229 $461.1K 2025-11-28 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2025-09-29 Muhsin Bilal Former Affiliate 25,061 $3.55M 2025-09-29 Charles Schwab & Co., Inc. — EDGAR
2025-09-26 Muhsin Bilal Former Affiliate 50,000 $7.09M 2025-09-26 Charles Schwab & Co., Inc. — EDGAR
2025-09-23 Muhsin Bilal Former Affiliate 25,000 $3.52M 2025-09-23 Charles Schwab & Co., Inc. — EDGAR
2025-05-13 REYNOLDS CRAIG B Former Director 16,443 $2.70M 2025-05-13 Charles Schwab & Co., Inc. — EDGAR
2025-05-12 Muhsin Bilal Officer 10,000 $1.63M 2025-05-12 Charles Schwab & Co., Inc. 10b5-1 EDGAR
2025-05-12 Chapek Robert A Former Affiliate 3,455 $564.6K 2025-05-12 Charles Schwab & Co., Inc. — EDGAR
2025-04-24 McClenahan Thomas Samuel Former Officer 26,300 $4.29M 2025-04-24 Charles Schwab & Co., Inc. — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-04 0001104659-26-054512 EDGAR
2026-04-23 0001104659-26-047839 EDGAR
2026-02-17 0001104659-26-015904 EDGAR
2026-01-12 0000937556-26-000005 EDGAR
2025-12-03 0000937556-25-000175 EDGAR
2025-12-01 0000937556-25-000171 EDGAR
2025-11-04 0000937556-25-000160 EDGAR
2025-09-29 0000937556-25-000151 EDGAR
2025-09-23 0000937556-25-000138 EDGAR
2025-08-19 0000937556-25-000127 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-27 0000937556-26-000017 EDGAR
2025-02-25 0000937556-25-000032 EDGAR
2024-02-28 0000937556-24-000018 EDGAR
2023-03-01 0000937556-23-000016 EDGAR
2022-02-16 0000937556-22-000031 EDGAR
2021-02-23 0000937556-21-000033 EDGAR
2020-02-19 0000937556-20-000030 EDGAR
2019-02-26 0000937556-19-000039 EDGAR
2018-02-28 0000937556-18-000019 EDGAR
2017-02-15 0000937556-17-000045 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-05 0000937556-26-000063 EDGAR
2025-11-04 0000937556-25-000161 EDGAR
2025-08-05 0000937556-25-000108 EDGAR
2025-05-06 0000937556-25-000082 EDGAR
2024-11-06 0000937556-24-000109 EDGAR
2024-08-07 0000937556-24-000064 EDGAR
2024-05-07 0000937556-24-000042 EDGAR
2023-11-08 0000937556-23-000222 EDGAR
2023-08-08 0000937556-23-000195 EDGAR
2023-05-10 0000937556-23-000068 EDGAR
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$1.40
TTM Revenue
$1.56B
TTM Net Income
$76.30M
TTM Op. Cash Flow
$232.00M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '262026-04-04$403.60M$57.10M$1.09$45.30M
Q4 '252026-01-03$412.50M$68.30M$1.21$60.50M
Q3 '252025-09-27$371.50M$-100.40M$-1.84$56.80M
Q2 '252025-06-28$370.90M$51.30M$0.94$69.40M
Q1 '252025-03-29$372.00M$-170.70M$-3.12$31.10M
Q4 '242024-12-28$368.40M$-349.60M$-6.43$50.50M
Q3 '242024-09-28$343.30M$9.80M$0.18$25.60M
Q2 '242024-06-29$343.90M$16.00M$0.30$74.50M
Q1 '242024-03-30$339.60M$18.90M$0.35$45.80M
Q4 '232023-12-30$548.90M$33.90M$0.63$68.60M
Q3 '232023-09-30$478.90M$10.60M$0.20$-4.60M
Q2 '232023-07-01$455.30M$15.70M$0.29$19.20M
Q1 2026 • period ending 2026-04-04 • filed 2026-05-05
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
0.00
P/B
—
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
9.7%
ROA
4.6%
Div Yield
0.00%
FCF Yield
—
Debt/Equity
0.56
Current Ratio
—
Market Cap
$0.00
as of 2026-06-10
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
3.50M
SI % of Float
7.77%
Days to Cover
3.65
Short Vol Ratio
67.5%
Free Float
45.07M
Float %
86.2%
Short interest 2026-05-29 • Short volume 2026-06-09 • Float 2026-03-12